Aegon


The Life cycle

12/05/22 -"Aegon’s Q1 22 results were good on an operating basis however profitability was hit by non-operating items, namely fair value items, as a result of tumbling equity markets. The strong capital ..."

Pages
48
Language
English
Published on
12/05/22
You may also be interested by these reports :
24/05/22
Buying into Scor (Add, France) amounted buying into Dennis Kessler’s vision. The CEO is now Chairman, still too influential but the exit is closer. ...

24/05/22
Our target price is slightly downgraded as we integrate the Q1 22 figures into our model. Most of the downgrade is driven by the EPS cut for FY 22 ...

19/05/22
Strong Q1 22 results posted by Generali. Both Life and Non-life have disclosed strong performances top-line wise and in terms of profitability ...

18/05/22
Aviva’s Q1 22 trading update was slightly above our expectations although this remains very much tied to the top-line and profitability could be ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO